Anavex Life Sciences Corp (AVXL)

[Steady_T]

So what? Missling has managed the company's finances just fine without those institutional investors.

Once there is an approved drug those instys will be knocking on the door. My take is that Anavex is still viewed by those instys as a high risk, untried approach to treating CNS diseases. As such they don't want the risk. Once the risk is reduced to a level they find acceptable they will buy into Anavex.

The MOA still has to be validated by an approval. Once that happens a whole lot of folks will take Anavex seriously. Till then it is just another high risk developmental biotech with an extremely novel approach addressing diseases that have proven to be intractable so far.

I think you are putting the cart before the horse.